(Q38003106)

26 August 2017

title

Erythropoietin and erythropoiesis stimulating agents (English)

1 reference

26 August 2017

1 reference

Nataša Debeljak

1

1 reference

26 August 2017

Arthur J Sytkowski

series ordinal

2

1 reference

26 August 2017

language of work or name

1 reference

16 April 2012

1 reference

Drug Testing and Analysis

26 August 2017

published in

1 reference

26 August 2017

volume

4

1 reference

26 August 2017

issue

11

1 reference

26 August 2017

page(s)

805-812

1 reference

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial

26 August 2017

cites work

1 reference

7 January 2021

Efficacy and safety of epoetin alfa in critically ill patients

1 reference

7 January 2021

American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer

1 reference

7 January 2021

Erythropoiesis-stimulating agents in the treatment of anaemia in cancer patients: ESMO Clinical Practice Guidelines for use

1 reference

7 January 2021

Erythropoietin as a novel brain and kidney protective agent.

1 reference

7 January 2021

The neurobiology of erythropoietin

1 reference

7 January 2021

Do non-hemopoietic effects of erythropoietin play a beneficial role in heart failure?

1 reference

7 January 2021

Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response

1 reference

7 January 2021

Detection of DNA-recombinant human epoetin-alfa as a pharmacological ergogenic aid.

1 reference

7 January 2021

A high-throughput test to detect C.E.R.A. doping in blood

1 reference

7 January 2021

SARCOSYL-PAGE: a new method for the detection of MIRCERA- and EPO-doping in blood

1 reference

7 January 2021

Isolation and characterization of genomic and cDNA clones of human erythropoietin

1 reference

7 January 2021

Cloning and expression of the human erythropoietin gene

1 reference

7 January 2021

Regional assignment of the erythropoietin gene to human chromosome region 7pter----q22.

1 reference

7 January 2021

Human erythropoietin gene: high level expression in stably transfected mammalian cells and chromosome localization

1 reference

7 January 2021

Erythropoietin: structure, control of production, and function

1 reference

7 January 2021

Hypoxia-induced erythropoietin production: a paradigm for oxygen-regulated gene expression

1 reference

7 January 2021

Control of erythropoietin gene expression and its use in medicine

1 reference

7 January 2021

Oxygen-regulated expression of the erythropoietin gene in the human renal cell line REPC.

1 reference

7 January 2021

Glycopeptide profiling of human urinary erythropoietin by matrix-assisted laser desorption/ionization mass spectrometry

1 reference

7 January 2021

Biological activity and structural stability of N-deglycosylated recombinant human erythropoietin

1 reference

7 January 2021

Role of glycosylation on the secretion and biological activity of erythropoietin

1 reference

7 January 2021

Co-localization of erythropoietin mRNA and ecto-5'-nucleotidase immunoreactivity in peritubular cells of rat renal cortex indicates that fibroblasts produce erythropoietin

1 reference

7 January 2021

Sites of erythropoietin production

1 reference

7 January 2021

Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus

1 reference

7 January 2021

Alanine scanning mutagenesis of human erythropoietin identifies four amino acids which are critical for biological activity

1 reference

7 January 2021

Dimerization of the extracellular domain of the erythropoietin (EPO) receptor by EPO: one high-affinity and one low-affinity interaction

1 reference

7 January 2021

The non-haematopoietic biological effects of erythropoietin

1 reference

7 January 2021

Beneficial and ominous aspects of the pleiotropic action of erythropoietin

1 reference

7 January 2021

New avenues of exploration for erythropoietin

1 reference

7 January 2021

Expression cloning of the murine erythropoietin receptor

1 reference

7 January 2021

Genomic organization of the human erythropoietin receptor gene

1 reference

7 January 2021

Effects of intermittent hypoxia on erythropoietin, soluble erythropoietin receptor and ventilation in humans

1 reference

7 January 2021

Enzyme-linked immunosorbent assay detects a potential soluble form of the erythropoietin receptor in human plasma.

1 reference

7 January 2021

Erythropoietin receptor and hematological disease

1 reference

7 January 2021

Structural design and molecular evolution of a cytokine receptor superfamily

1 reference

7 January 2021

Photoaffinity labeling of the erythropoietin receptor and its identification in a ligand-free form

1 reference

7 January 2021

Signaling through the hematopoietic cytokine receptors.

1 reference

7 January 2021

The conserved box 1 motif of cytokine receptors is required for association with JAK kinases

1 reference

7 January 2021

Activation of erythropoietin signaling by receptor dimerization

1 reference

7 January 2021

Receptor dimerization in GH and erythropoietin action--it takes two to tango, but how?

1 reference

7 January 2021

The structure, organization, activation and plasticity of the erythropoietin receptor

1 reference

7 January 2021

Active human erythropoietin expressed in insect cells using a baculovirus vector: a role for N-linked oligosaccharide

1 reference

7 January 2021

Epoetin delta is effective for the management of anaemia associated with chronic kidney disease

1 reference

7 January 2021

Development and characterization of novel erythropoiesis stimulating protein (NESP).

1 reference

7 January 2021

Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin

1 reference

7 January 2021

Effect of a continuous erythropoietin receptor activator (C.E.R.A.) on stable haemoglobin in patients with CKD on dialysis: once monthly administration.

1 reference

7 January 2021

Characterization of recombinant human erythropoietin produced in Chinese hamster ovary cells

1 reference

7 January 2021

Sugar profiling proves that human serum erythropoietin differs from recombinant human erythropoietin

1 reference

7 January 2021

Detection of isoelectric profiles of erythropoietin in urine: differentiation of natural and administered recombinant hormones

1 reference

7 January 2021

Isoelectric profiles of human erythropoietin are different in serum and urine

1 reference

7 January 2021

Detection of recombinant human erythropoietin in urine for doping analysis: Interpretation of isoelectric profiles by discriminant analysis

1 reference

7 January 2021

Rapid detection of erythropoiesis-stimulating agents in urine and serum.

1 reference

7 January 2021

Site-specific antibodies to human erythropoietin directed toward the NH2-terminal region

1 reference

7 January 2021

1 reference

7 January 2021

Evaluation of the safety and pharmacodynamics of Hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteers.

1 reference

7 January 2021

A phase I, single and fractionated, ascending-dose study evaluating the safety, pharmacokinetics, pharmacodynamics, and immunogenicity of an erythropoietin mimetic antibody fusion protein (CNTO 528) in healthy male subjects

1 reference

7 January 2021

CNTO 530: molecular pharmacology in human UT-7EPO cells and pharmacokinetics and pharmacodynamics in mice

1 reference

7 January 2021

Production and characterization of long-acting recombinant human albumin-EPO fusion protein expressed in CHO cell

1 reference

7 January 2021

Biochemical characterization of rhEpo-Fc fusion protein expressed in CHO cells.

1 reference

7 January 2021

Development of a long-acting erythropoietin by fusing the carboxyl-terminal peptide of human chorionic gonadotropin beta-subunit to the coding sequence of human erythropoietin

1 reference

7 January 2021

Human erythropoietin dimers with markedly enhanced in vivo activity

1 reference

7 January 2021

An erythropoietin fusion protein comprised of identical repeating domains exhibits enhanced biological properties

1 reference

7 January 2021

Production of recombinant human GM-CSF-EPO hybrid proteins: in vitro biological characterization.

1 reference

7 January 2021

Anti-glycophorin single-chain Fv fusion to low-affinity mutant erythropoietin improves red blood cell-lineage specificity

1 reference

7 January 2021

Drug targeting of erythropoietin across the primate blood-brain barrier with an IgG molecular Trojan horse

1 reference

7 January 2021

Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury

1 reference

7 January 2021

Prolyl hydroxylase domain-containing protein inhibitors as stabilizers of hypoxia-inducible factor: small molecule-based therapeutics for anemia

1 reference

7 January 2021

Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD.

1 reference

7 January 2021

Oral administration of K-11706 inhibits GATA binding activity, enhances hypoxia-inducible factor 1 binding activity, and restores indicators in an in vivo mouse model of anemia of chronic disease

1 reference

7 January 2021

Dose response to a single intramuscular injection of recombinant adeno-associated virus-erythropoietin in monkeys

1 reference

7 January 2021

Transfer of the feline erythropoietin gene to cats using a recombinant adeno-associated virus vector

1 reference

7 January 2021

Long-term erythropoietin expression in rodents and non-human primates following intramuscular injection of a replication-defective adenoviral vector

1 reference

7 January 2021

Autoimmune anemia in macaques following erythropoietin gene therapy

1 reference

7 January 2021

Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer.

1 reference

7 January 2021

Long-term reversal of chronic anemia using a hypoxia-regulated erythropoietin gene therapy

1 reference

7 January 2021

Human erythropoietin gene therapy for patients with chronic renal failure

1 reference

7 January 2021

“Genetic Doping” with erythropoietin cDNA in primate muscle is detectable

1 reference

7 January 2021

The molecular structure of human erythropoietin.

1 reference

7 January 2021

Identifiers

DOI

10.1002/DTA.1341

1 reference

26 August 2017

1 reference